Eagle Pharmaceuticals
EGRX
#9808
Rank
โ‚น4.16 B
Marketcap
โ‚น321.33
Share price
0.00%
Change (1 day)
-24.02%
Change (1 year)

Revenue for Eagle Pharmaceuticals (EGRX)

Revenue in 2023 (TTM): โ‚น21.13 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น22.42 Billion. In 2022 the company made a revenue of โ‚น26.19 Billion an increase over the revenue in the year 2021 that were of โ‚น12.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eagle Pharmaceuticals from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น21.13 B-19.32%
2022 โ‚น26.19 B105.19%
2021 โ‚น12.76 B-7.04%
2020 โ‚น13.73 B-1.68%
2019 โ‚น13.96 B-6.34%
2018 โ‚น14.91 B-1.31%
2017 โ‚น15.11 B17.38%
2016 โ‚น12.87 B192.56%
2015 โ‚น4.40 B261.54%
2014 โ‚น1.21 B11.4%
2013 โ‚น1.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น7.778 T 34,584.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.534 T 15,658.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚น4.634 T 20,564.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚น1.446 T 6,351.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น2.971 T 13,150.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น4.267 T 18,926.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.148 T 18,395.75%๐Ÿ‡บ๐Ÿ‡ธ USA